Translational & Clinical
Showing 231 - 240 of 266 posts
https://www.coltonconsortium.org/publications/clinical-and-ultrasound-features-of-a-cohort-of-psoriasis-patients-without-musculoskeletal-symptoms-a-prospective-and-multicenter-study/
https://www.coltonconsortium.org/publications/clinical-characteristics-and-outcomes-of-polyarteritis-nodosa-an-international-study/
https://www.coltonconsortium.org/publications/clns1a-regulates-genome-stability-and-cell-cycle-progression-to-control-cd4-t-cell-function-and-autoimmunity/
https://www.coltonconsortium.org/publications/a-lupus-derived-autoantibody-that-binds-to-intracellular-rna-activates-cgas-mediated-tumor-immunity-and-can-deliver-rna-into-cells/
https://www.coltonconsortium.org/publications/comparison-of-eular-printo-pres-ankara-2008-and-2022-acr-eular-classification-criteria-for-granulomatosis-with-polyangiitis-in-children/
https://www.coltonconsortium.org/publications/a-phase-3-trial-of-upadacitinib-for-giant-cell-arteritis/
https://www.coltonconsortium.org/publications/a-randomized-double-blind-placebo-controlled-trial-of-abatacept-for-the-treatment-of-relapsing-non-severe-granulomatosis-with-polyangiitis/
https://www.coltonconsortium.org/publications/a-retrospective-evaluation-of-glucagon-like-peptide-1-receptor-agonists-in-systemic-lupus-erythematosus-patients/
https://www.coltonconsortium.org/news/yale-news-spotlights-the-colton-center-as-a-key-driver-of-autoimmune-innovation-at-yale-ventures/
A Yale News feature on Yale Ventures' five accelerator funds highlights the Colton Center for Autoimmunity's growing role in translating autoimmune research into startups, licenses, and real-world therapies.
https://www.coltonconsortium.org/news/yale-researchers-use-machine-learning-to-improve-personalized-cancer-vaccine-design/
A Colton-supported Yale study has produced ImmunoStruct, a machine learning model that improves personalized cancer vaccine design by incorporating the 3D structure of immune-activating peptides — now licensed to a Yale spinout.
